Avandia increases risk of heart problems
Controversial diabetes drug Avandia does increase the risk of heart problems, a key panel of experts charged with deciding whether to pull the drug from the US markets said on Wednesday.
LONDON, Sept. 23, 2010-The European Medicines Agency today recommended the suspension of the marketing authorisations for the rosiglitazone-containing anti-diabetes medicines Avandia, Avandamet and Avaglim.